Glenview Trust Co Purchases 2,222 Shares of Intuitive Surgical, Inc. $ISRG

Glenview Trust Co increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 116,662 shares of the medical equipment provider’s stock after purchasing an additional 2,222 shares during the period. Intuitive Surgical accounts for 1.0% of Glenview Trust Co’s portfolio, making the stock its 24th largest holding. Glenview Trust Co’s holdings in Intuitive Surgical were worth $66,073,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Genus Capital Management Inc. bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at $228,000. HBK Sorce Advisory LLC raised its position in shares of Intuitive Surgical by 5.8% during the 4th quarter. HBK Sorce Advisory LLC now owns 3,967 shares of the medical equipment provider’s stock valued at $2,247,000 after purchasing an additional 219 shares during the period. Allen Capital Group LLC raised its position in shares of Intuitive Surgical by 15.3% during the 4th quarter. Allen Capital Group LLC now owns 1,254 shares of the medical equipment provider’s stock valued at $710,000 after purchasing an additional 166 shares during the period. Hantz Financial Services Inc. raised its position in shares of Intuitive Surgical by 105.6% during the 4th quarter. Hantz Financial Services Inc. now owns 31,772 shares of the medical equipment provider’s stock valued at $17,994,000 after purchasing an additional 16,322 shares during the period. Finally, Simplify Asset Management Inc. increased its holdings in Intuitive Surgical by 92.9% in the 4th quarter. Simplify Asset Management Inc. now owns 14,740 shares of the medical equipment provider’s stock valued at $8,348,000 after acquiring an additional 7,100 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insider Transactions at Intuitive Surgical

In other news, SVP Mark Brosius sold 645 shares of the business’s stock in a transaction dated Monday, March 9th. The shares were sold at an average price of $485.01, for a total value of $312,831.45. Following the sale, the senior vice president directly owned 1,613 shares in the company, valued at $782,321.13. The trade was a 28.57% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Myriam Curet sold 105 shares of the business’s stock in a transaction dated Tuesday, March 10th. The stock was sold at an average price of $493.95, for a total transaction of $51,864.75. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 5,701 shares of company stock worth $2,783,807. 0.60% of the stock is currently owned by corporate insiders.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $438.10 on Monday. The company’s 50-day moving average price is $458.62 and its 200-day moving average price is $510.37. Intuitive Surgical, Inc. has a twelve month low of $417.74 and a twelve month high of $603.88. The company has a market cap of $155.16 billion, a PE ratio of 53.10, a price-to-earnings-growth ratio of 3.50 and a beta of 1.51.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The firm had revenue of $2.77 billion for the quarter, compared to the consensus estimate of $2.62 billion. During the same period in the previous year, the firm posted $1.81 EPS. The business’s quarterly revenue was up 23.0% on a year-over-year basis. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current fiscal year.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive unveiled more than 100 upcoming upgrades for its da Vinci 5 robotic surgery system, including improved force-feedback tools, telecollaboration features, and security/reliability enhancements, which could strengthen the company’s competitive moat and support future procedure growth. Intuitive Surgical’s Da Vinci 5 Upgrades Aim To Deepen Moat For Investors
• Positive Sentiment: Intuitive also announced innovations tied to its “Quintuple Aim” strategy, reinforcing product development momentum and the company’s push to improve surgeon autonomy and operating-room efficiency. Intuitive Announces Innovations to Advance Quintuple Aim
• Positive Sentiment: Wall Street commentary remains moderately optimistic, with analysts still bullish on Intuitive Surgical’s long-term prospects despite recent underperformance versus the broader market. Are Wall Street Analysts Bullish on Intuitive Surgical Stock?
• Neutral Sentiment: Investor interest continues around the SP platform, where strong procedure growth suggests an important future opportunity, but it remains unclear whether this is true addressable-market expansion or mostly a shift within existing robotic procedures. ISRG’s SP Platform: Early-Stage Growth or Next TAM Expansion Driver?
• Neutral Sentiment: There was also minor insider selling by an executive, but the transactions were very small and made under a pre-arranged 10b5-1 plan, so the signal for investors is limited. Mark Brosius insider transaction
• Negative Sentiment: The stock has also been hurt by recent weakness after earnings, with market commentary noting a roughly 7% decline since the last report, reflecting concern that the shares may need more proof of sustained acceleration. Why Is Intuitive Surgical (ISRG) Down 7.2% Since Last Earnings Report?
• Negative Sentiment: Several articles also point out that ISRG has significantly lagged the market over the past six months, which may be keeping valuation-sensitive investors on the sidelines. 3 Big Reasons ISRG Should Be On Your Watchlist

Analysts Set New Price Targets

A number of analysts have issued reports on the stock. Bank of America reduced their price target on shares of Intuitive Surgical from $650.00 to $520.00 and set a “buy” rating on the stock in a report on Monday, May 18th. Leerink Partners reduced their price target on shares of Intuitive Surgical from $622.00 to $573.00 and set an “outperform” rating on the stock in a report on Wednesday, April 22nd. Citigroup upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price target on the stock in a report on Wednesday, March 11th. Evercore reduced their price target on shares of Intuitive Surgical from $550.00 to $480.00 and set a “neutral” rating on the stock in a report on Monday, April 6th. Finally, Robert W. Baird lifted their price target on shares of Intuitive Surgical from $575.00 to $610.00 and gave the company an “outperform” rating in a report on Wednesday, April 22nd. Nineteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $579.33.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.